Indeed, several studies have indicated that CTLA-8 (IL-17) may stimulate cancer cells to produce angiogenic factors like VEGF, thereby enhancing tumor angiogenesis and growth via STAT3 signaling (34–37). Here, STAT3 is linked to cancer.